Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line

<p>Abstract</p> <p>Background</p> <p>Photodynamic therapy (PDT) involves excitation of sensitizer molecules by visible light in the presence of molecular oxygen, thereby generating reactive oxygen species (ROS) through electron/energy transfer processes. The ROS, thus p...

Full description

Bibliographic Details
Main Authors: Muralidhar K, Dwarakanath Bilikere S, Gupta Seema, Koru-Sengul Tulay, Jain Viney
Format: Article
Language:English
Published: BMC 2010-04-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/8/1/43
id doaj-ccfefccdc7704284ae4ecf533411ab2c
record_format Article
spelling doaj-ccfefccdc7704284ae4ecf533411ab2c2020-11-25T00:24:46ZengBMCJournal of Translational Medicine1479-58762010-04-01814310.1186/1479-5876-8-43Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell lineMuralidhar KDwarakanath Bilikere SGupta SeemaKoru-Sengul TulayJain Viney<p>Abstract</p> <p>Background</p> <p>Photodynamic therapy (PDT) involves excitation of sensitizer molecules by visible light in the presence of molecular oxygen, thereby generating reactive oxygen species (ROS) through electron/energy transfer processes. The ROS, thus produced can cause damage to both the structure and the function of the cellular constituents resulting in cell death. Our preliminary investigations of dose-response relationships in a human glioma cell line (BMG-1) showed that disulphonated aluminum phthalocyanine (AlPcS<sub>2</sub>) photodynamically induced loss of cell survival in a concentration dependent manner up to 1 μM, further increases in AlPcS<sub>2</sub>concentration (>1 μM) were, however, observed to decrease the photodynamic toxicity. Considering the fact that for most photosensitizers only monotonic dose-response (survival) relationships have been reported, this result was unexpected. The present studies were, therefore, undertaken to further investigate the concentration dependent photodynamic effects of AlPcS<sub>2</sub>.</p> <p>Methods</p> <p>Concentration-dependent cellular uptake, sub-cellular localization, proliferation and photodynamic effects of AlPcS<sub>2 </sub>were investigated in BMG-1 cells by absorbance and fluorescence measurements, image analysis, cell counting and colony forming assays, flow cytometry and micronuclei formation respectively.</p> <p>Results</p> <p>The cellular uptake as a function of extra-cellular AlPcS<sub>2 </sub>concentrations was observed to be biphasic. AlPcS<sub>2 </sub>was distributed throughout the cytoplasm with intense fluorescence in the perinuclear regions at a concentration of 1 μM, while a weak diffuse fluorescence was observed at higher concentrations. A concentration-dependent decrease in cell proliferation with accumulation of cells in G<sub>2</sub>+M phase was observed after PDT. The response of clonogenic survival after AlPcS<sub>2</sub>-PDT was non-monotonic with respect to AlPcS<sub>2 </sub>concentration.</p> <p>Conclusions</p> <p>Based on the results we conclude that concentration-dependent changes in physico-chemical properties of sensitizer such as aggregation may influence intracellular transport and localization of photosensitizer. Consequent modifications in the photodynamic induction of lesions and their repair leading to different modes of cell death may contribute to the observed non-linear effects.</p> http://www.translational-medicine.com/content/8/1/43
collection DOAJ
language English
format Article
sources DOAJ
author Muralidhar K
Dwarakanath Bilikere S
Gupta Seema
Koru-Sengul Tulay
Jain Viney
spellingShingle Muralidhar K
Dwarakanath Bilikere S
Gupta Seema
Koru-Sengul Tulay
Jain Viney
Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
Journal of Translational Medicine
author_facet Muralidhar K
Dwarakanath Bilikere S
Gupta Seema
Koru-Sengul Tulay
Jain Viney
author_sort Muralidhar K
title Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
title_short Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
title_full Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
title_fullStr Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
title_full_unstemmed Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
title_sort non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2010-04-01
description <p>Abstract</p> <p>Background</p> <p>Photodynamic therapy (PDT) involves excitation of sensitizer molecules by visible light in the presence of molecular oxygen, thereby generating reactive oxygen species (ROS) through electron/energy transfer processes. The ROS, thus produced can cause damage to both the structure and the function of the cellular constituents resulting in cell death. Our preliminary investigations of dose-response relationships in a human glioma cell line (BMG-1) showed that disulphonated aluminum phthalocyanine (AlPcS<sub>2</sub>) photodynamically induced loss of cell survival in a concentration dependent manner up to 1 μM, further increases in AlPcS<sub>2</sub>concentration (>1 μM) were, however, observed to decrease the photodynamic toxicity. Considering the fact that for most photosensitizers only monotonic dose-response (survival) relationships have been reported, this result was unexpected. The present studies were, therefore, undertaken to further investigate the concentration dependent photodynamic effects of AlPcS<sub>2</sub>.</p> <p>Methods</p> <p>Concentration-dependent cellular uptake, sub-cellular localization, proliferation and photodynamic effects of AlPcS<sub>2 </sub>were investigated in BMG-1 cells by absorbance and fluorescence measurements, image analysis, cell counting and colony forming assays, flow cytometry and micronuclei formation respectively.</p> <p>Results</p> <p>The cellular uptake as a function of extra-cellular AlPcS<sub>2 </sub>concentrations was observed to be biphasic. AlPcS<sub>2 </sub>was distributed throughout the cytoplasm with intense fluorescence in the perinuclear regions at a concentration of 1 μM, while a weak diffuse fluorescence was observed at higher concentrations. A concentration-dependent decrease in cell proliferation with accumulation of cells in G<sub>2</sub>+M phase was observed after PDT. The response of clonogenic survival after AlPcS<sub>2</sub>-PDT was non-monotonic with respect to AlPcS<sub>2 </sub>concentration.</p> <p>Conclusions</p> <p>Based on the results we conclude that concentration-dependent changes in physico-chemical properties of sensitizer such as aggregation may influence intracellular transport and localization of photosensitizer. Consequent modifications in the photodynamic induction of lesions and their repair leading to different modes of cell death may contribute to the observed non-linear effects.</p>
url http://www.translational-medicine.com/content/8/1/43
work_keys_str_mv AT muralidhark nonmonotonicchangesinclonogeniccellsurvivalinducedbydisulphonatedaluminumphthalocyaninephotodynamictreatmentinahumangliomacellline
AT dwarakanathbilikeres nonmonotonicchangesinclonogeniccellsurvivalinducedbydisulphonatedaluminumphthalocyaninephotodynamictreatmentinahumangliomacellline
AT guptaseema nonmonotonicchangesinclonogeniccellsurvivalinducedbydisulphonatedaluminumphthalocyaninephotodynamictreatmentinahumangliomacellline
AT korusengultulay nonmonotonicchangesinclonogeniccellsurvivalinducedbydisulphonatedaluminumphthalocyaninephotodynamictreatmentinahumangliomacellline
AT jainviney nonmonotonicchangesinclonogeniccellsurvivalinducedbydisulphonatedaluminumphthalocyaninephotodynamictreatmentinahumangliomacellline
_version_ 1725351744144146432